115 related articles for article (PubMed ID: 15931883)
21. Hemodialysis performance and anticoagulant activities of PVP-k25 and carboxylic-multiwall nanotube composite blended Polyethersulfone membrane.
Irfan M; Irfan M; Shah SM; Baig N; Saleh TA; Ahmed M; Naz G; Akhtar N; Muhammad N; Idris A
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109769. PubMed ID: 31349444
[TBL] [Abstract][Full Text] [Related]
22. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation.
De Sanctis LB; Stefoni S; Cianciolo G; Colì L; Buscaroli A; Feliciangeli G; Borgnino LC; Bonetti M; Gregorini MC; De Giovanni P; Buttazzi R
Int J Artif Organs; 1996 Jul; 19(7):404-10. PubMed ID: 8841854
[TBL] [Abstract][Full Text] [Related]
23. Overview of PES biocompatible/hemodialysis membranes: PES-blood interactions and modification techniques.
Irfan M; Idris A
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():574-92. PubMed ID: 26249629
[TBL] [Abstract][Full Text] [Related]
24. Deviations in coagulation activation due to treatment with different haemodialysis membranes.
Bartels PC; Schoorl M; Schoorl M; Nubé MJ
Scand J Clin Lab Invest; 2003; 63(6):417-24. PubMed ID: 14594322
[TBL] [Abstract][Full Text] [Related]
25. Route to hemocompatible polyethersulfone membranes via surface aminolysis and heparinization.
Wang L; Cai Y; Jing Y; Zhu B; Zhu L; Xu Y
J Colloid Interface Sci; 2014 May; 422():38-44. PubMed ID: 24655826
[TBL] [Abstract][Full Text] [Related]
26. Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients.
Andreoli MC; Dalboni MA; Watanabe R; Manfredi SR; Canziani ME; Kallás EG; Sesso RC; Draibe SA; Balakrishnan VS; Jaber BL; Liangos O; Cendoroglo M
Artif Organs; 2007 Dec; 31(12):887-92. PubMed ID: 17924987
[TBL] [Abstract][Full Text] [Related]
27. Proteins adsorbed to a polysulfone hemodialysis membrane under heparin and citrate anticoagulation regimens.
Mares J; Tuma Z; Moravec J; Pavlina R; Matejovic M
Artif Organs; 2019 Nov; 43(11):1092-1103. PubMed ID: 31162876
[TBL] [Abstract][Full Text] [Related]
28. Biocompatibility of membranes used in the treatment of renal failure.
Hoenich NA; Woffindin C; Mathews JN; Vienken J
Biomaterials; 1995 May; 16(8):587-92. PubMed ID: 7548608
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of polyethersulfone highflux hemodialysis membrane in vitro and in vivo.
Su BH; Fu P; Li Q; Tao Y; Li Z; Zao HS; Zhao CS
J Mater Sci Mater Med; 2008 Feb; 19(2):745-51. PubMed ID: 17619985
[TBL] [Abstract][Full Text] [Related]
30. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
[TBL] [Abstract][Full Text] [Related]
32. Heparin-like macromolecules for the modification of anticoagulant biomaterials.
Ran F; Nie S; Li J; Su B; Sun S; Zhao C
Macromol Biosci; 2012 Jan; 12(1):116-25. PubMed ID: 21976247
[TBL] [Abstract][Full Text] [Related]
33. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
[TBL] [Abstract][Full Text] [Related]
34. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis.
Fu X; Ning JP
J Mater Sci Mater Med; 2018 May; 29(5):66. PubMed ID: 29744595
[TBL] [Abstract][Full Text] [Related]
36. Zwitterionic glycosyl modified polyethersulfone membranes with enhanced anti-fouling property and blood compatibility.
Xie Y; Li SS; Jiang X; Xiang T; Wang R; Zhao CS
J Colloid Interface Sci; 2015 Apr; 443():36-44. PubMed ID: 25528533
[TBL] [Abstract][Full Text] [Related]
37. [In vitro study of C3a des Arg produced by plasma incubation with blood purification materials].
Huang J; Cheng L; Yue Y; Wei Q
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Dec; 17(4):385-9. PubMed ID: 11211820
[TBL] [Abstract][Full Text] [Related]
38. Heparin-like surface modification of polyethersulfone membrane and its biocompatibility.
Tang M; Xue J; Yan K; Xiang T; Sun S; Zhao C
J Colloid Interface Sci; 2012 Nov; 386(1):428-40. PubMed ID: 22909969
[TBL] [Abstract][Full Text] [Related]
39. Biocompatibility of modified polyethersulfone membranes by blending an amphiphilic triblock co-polymer of poly(vinyl pyrrolidone)-b-poly(methyl methacrylate)-b-poly(vinyl pyrrolidone).
Ran F; Nie S; Zhao W; Li J; Su B; Sun S; Zhao C
Acta Biomater; 2011 Sep; 7(9):3370-81. PubMed ID: 21658478
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
